Study of Pharmacokinetics in HIV-infected Women

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
HIV Infections
Interventions
DRUG

antiretroviral treatment

These antiretroviral drugs are a part of the participant's current drug regimen.

Trial Locations (15)

V6H 3N1

Children and Women's Hospital, Vancouver

V6Z 1Y6

St. Paul's Hospital, Vancouver

V6Z 2C7

Downtown Infectious Diseases Clinic, Vancouver

B3H 1V7

Capital District Health Authority, Halifax

L8N 3Z5

Hamilton Health Sciences - McMaster University, Hamilton

K1N 6N5

University of Ottawa Health Services, Ottawa

K1Y 4E9

Ottawa Health Research Institute, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5B 1L6

Canadian Immunodeficiency Research Collaborative, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

M5G 2N2

University Health Network - Toronto General Hospital, Toronto

N8W 1E3

Windsor Regional Hospital HIV Care Program, Windsor

H2W 1T7

Centre de recherche du Centre hospitalier de l'Universite de Montreal (CHUM), Montreal

H2X 2P4

Montreal Chest Institute, Montreal

G1V 4G2

Chuq/Chul, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Women's College Hospital

OTHER

NCT00433979 - Study of Pharmacokinetics in HIV-infected Women | Biotech Hunter | Biotech Hunter